%0 Journal Article
%T 双相抑郁的治疗进展<br>Progress in Treatment of Bipolar Depression
%A 贾琳
%A 孟祥军
%J Advances in Clinical Medicine
%P 414-419
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/acm.2024.1461790
%X 双相抑郁是一种复发性疾病，对患者及社会造成严重的负担。目前美国食品药品监督管理局共批准了五种治疗双相抑郁的方案。其中四种是应用第二代抗精神病药物，一种是应用第二代抗精神病药物联合抗抑郁药物。本文回顾了上述五种方案及临床常被使用的药物及非药物治疗方案选择，期望对进一步治疗双相抑郁提供参考。<br />
Bipolar depression is a recurrent disease that causes serious burden to patients and society. Currently, the US Food and Drug Administration has approved five treatment plans for bipolar depression. Four of them are using second-generation antipsychotic drugs, and one is using second-generation antipsychotic drugs in combination with antidepressants. This article reviews the above five regimens and the commonly used drug and non drug treatment options in clinical practice, with the hope of providing reference for further treatment of bipolar depression.
%K 双相情感障碍，抑郁，躁狂，治疗进展<br>Bipolar Disorder
%K Depression
%K Mania
%K Treatment Progress
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=89229